Coulter & Justus Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$416K Buy
14,988
+1,237
+9% +$34.3K 0.09% 68
2023
Q4
$396K Buy
+13,751
New +$416K 0.27% 25
2023
Q2
Sell
-5,178
Closed -$211K 49
2023
Q1
$211K Hold
5,178
0.14% 44
2022
Q4
$265K Hold
5,178
0.18% 44
2022
Q3
$227K Hold
5,178
0.18% 41
2022
Q2
$271K Buy
+5,178
New +$264K 0.22% 39
2022
Q1
Sell
-5,678
Closed -$335K 44
2021
Q4
$335K Buy
+5,678
New +$281K 0.26% 37

Other funds holding PFE

Coulter & Justus Financial Services's PFE Position: Q1 2024 in Review

Coulter & Justus Financial Services increased its Pfizer (PFE) stake by 9% in Q1 2024, buying an estimated $34.3K and bringing the position to 14,988 shares worth $416K. The position accounts for 0.09% of the portfolio, ranked #68.

Coulter & Justus Financial Services first reported a position in PFE in Q4 2021 and has held it in 7 quarters since. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Coulter & Justus Financial Services held 14,988 shares of Pfizer worth $416K as of Q1 2024.
  • Coulter & Justus Financial Services bought 1,237 Pfizer shares in Q1 2024, an estimated $34.3K.
  • Pfizer made up 0.09% of Coulter & Justus Financial Services's portfolio in Q1 2024, its #68 holding.
  • Coulter & Justus Financial Services first reported a position in Pfizer in Q4 2021 and has held it in 7 quarters since.
  • 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Coulter & Justus Financial Services's 13F filing for Q1 2024, filed 3 May 2024.